Skip to main content
BALCHEM CORP logo

BALCHEM CORP — Investor Relations & Filings

Ticker · BCPC ISIN · US0576652004 LEI · 549300VR70OPMHUI3557 US Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2012-06-20 Director's Dealing
Country US United States of America
Listing US BCPC

About BALCHEM CORP

https://balchem.com/

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products. The company operates through three primary segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health division is a leader in essential nutrients like choline, chelated minerals, and vitamin K2, utilizing advanced microencapsulation technologies for the food and nutritional supplement markets. The Animal Nutrition & Health segment provides a portfolio of products to meet the nutritional needs of animals, with a key position in choline chloride. The Specialty Products segment includes Performance Gases for various industrial applications and Plant Nutrition solutions. Balchem is focused on delivering innovative, science-based solutions to improve health and nutrition.

Recent filings

Filing Released Lang Actions
FORM 3
Director's Dealing
2012-06-20 English
BALCHEM CORPORATION 8-K 6-14-2012
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a Form 8-K filed with the SEC, dated June 14, 2012, reporting the results of the Annual Meeting of Stockholders. It includes detailed voting results for director elections, ratification of the independent auditor, and an advisory vote on executive compensation. The content focuses on the submission of matters to a vote of security holders, which matches the description of Declaration of Voting Results & Voting Rights Announcements (DVA). The document is not an Annual Report, Audit Report, or Management Report, nor is it a brief announcement or certification. It contains specific voting results, which is the key identifying feature for DVA filings.
2012-06-19 English
FORM 4
Director's Dealing
2012-06-18 English
BALCHEM CORP 8-K 5-29-2012
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content describes the suspension of sales of a specific product due to performance issues and mentions financial impact but does not contain comprehensive financial statements or detailed financial analysis. It is not an annual or quarterly report, nor is it an earnings release or management discussion. The document is relatively short (3148 characters) and serves as a regulatory announcement of a material event affecting the company. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2012-05-29 English
BALCHEM CORPORATION 10-Q 3-31-2012
Interim / Quarterly Report Q1 2012
2012-05-10 English
BALCHEM CORPORATION 8-K 5-2-2012
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 2, 2012, reporting earnings for the first quarter ended March 31, 2012. It includes a press release attached as Exhibit 99.1 that reports financial results. The text explicitly states it is a current report and the content is a press release announcing quarterly earnings results, which aligns with an Earnings Release. The document length is short (2713 characters), and it is not a full quarterly report but an announcement of results. Therefore, the appropriate classification is Earnings Release (ER).
2012-05-02 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.